US FDA approves Zevra's genetic disorder treatment-March 2024-www.financetom.com

US FDA approves Zevra's genetic disorder treatment

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves Zevra's genetic disorder treatment

Sep 20, 2024 10:40 AM

Sept 20 (Reuters) - The U.S. Food and Drug

Administration approved Zevra Therapeutics' ( ZVRA ) drug for a

rare and fatal genetic disorder, the first treatment to get a

nod for the condition, the health regulator said on Friday.

(Reporting by Sriparna Roy and Kashish Tandon in Bengaluru;

Editing by Devika Syamnath)

Previous page： Rewind 2020: Will New Year open up new horizons for the M&A space? Next page： Amazon gets into the podcast business

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Rewind 2020: Will New Year open up new horizons for the M&A space?

Dec 31, 2020

Merger and acquisition (M&A) activity slowed to a crawl at the start of 2020 but deal makers managed to find opportunities in adversity.

Amazon gets into the podcast business

Dec 31, 2020

This is a pivotal moment to expand the Amazon Music offering beyond music as listener habits evolve, Amazon said in a blog post-Wednesday.

NCC bags orders worth Rs 8,980 cr in December

Jan 1, 2021

These orders are received from Central/State Government agencies and do not include any internal orders, the company added.

Jubilant Foodworks to acquire 10.76% stake in Barbeque-Nation Hospitality for Rs 92 crore

Dec 31, 2020

Jubilant Foodworks Chairman Shyam S Bhartia and its Co-Chairman Hari S Bhartia said the proposed investment will create value for the company's shareholders.